Cleveland, OHNCT07454174Now EnrollingIRB Ready

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Clinical Trial in Cleveland, OH

Access cutting-edge autosomal dominant polycystic kidney disease (adpkd) treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Richard Fatica

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access autosomal dominant polycystic kidney disease (adpkd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autosomal dominant polycystic kidney disease (adpkd) treatment provided free

Apply for This Cleveland Location

Check if you qualify for this autosomal dominant polycystic kidney disease (adpkd) clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study in Cleveland

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.

Sponsor: Richard Fatica

Who Can Participate

Inclusion Criteria

Adult (18 years or older)
Diagnosis of ADPKD by a physician.
Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 at screening using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
Appropriate control of blood pressure (i.e. entry reading \<140/90) including the use of BP medications for diagnosis of hypertension.
BMI ≥ 25 (accounting for muscle mass)
Own an at-home blood pressure monitor (no brand requirements)
Able to complete study-related activities (e.g., attend online classes, complete questionnaires, and proper use of medical devices)

Exclusion Criteria

Intolerance or allergy to any of the ingredients in the provided medical food
Severe or rare underlying health conditions may cause a safety risk when taking the medical food. Those underlying health conditions will be assessed by the enrolling physician and include but are not limited to:
History of hyperkalemia
Heart failure
Liver cirrhosis
Chronic kidney disease stage 4 or greater, or other renal condition that severely impairs bone mineral homeostasis.
HIV infection
Chronic drug or alcohol abuse
Chronic malabsorption syndrome
Malignancy (non-melanoma skin cancer exempted)
Autoimmune disease
Pregnant, planning to be pregnant, or nursing during the course of the study
Chronic history of recurrent urinary tract infections (UTI) (≥ 3 UTIs per year)
Diagnosis of aneurysm
Indigestion due to hypochlorhydria (low stomach acid)
Any other condition, that in the opinion of the enrolling physician, makes the subject an unsuitable candidate for the study.
Current use of any of the following medications or supplements which could affect safety or compliance with this study:
The medical food, KetoCitra®.
Urine alkalizing agents such as sodium bicarbonate or potassium citrate
Citrate treatments
Immunosuppressive treatment
Potassium-sparing diuretics
Somatostatin analogs
Aluminum-containing supplements or medications such as aluminum antacids (e.g. Maalox) or aluminum-based phosphate binders.
SGLT2 inhibitors
Participation in another therapeutic intervention trial.
Following a highly specialized or extreme diet that is incompatible with the interventional nutrition program (e.g. carnivore, very high protein diet for elite athletes, etc.)
Food sensitivities or allergies that are incompatible with the interventional nutrition program.
The subject is already adhering to a form of a ketogenic diet or related fasting regimen.
Current or past history of disordered eating or feeding behaviors.
History of gastric bypass.
Active diagnosis of ulcerative colitis, Irritable Bowel Syndrome, Crohn's, or Gallbladder Disease.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT07454174) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Treatment Options in Cleveland, OH

If you're searching for autosomal dominant polycystic kidney disease (adpkd) treatment options in Cleveland, OH, this clinical trial (NCT07454174) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autosomal dominant polycystic kidney disease (adpkd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autosomal dominant polycystic kidney disease (adpkd) clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Cleveland, OH

See all heart attack clinical trials recruiting in Cleveland — not just this study.

Browse Heart Attack Trials in Cleveland →

Browse More Trials by Condition

Heart Attack TrialsAlzheimers Disease TrialsAnkylosing Spondylitis TrialsAtopic Dermatitis TrialsInterstitial Cystitis TrialsPolycystic Kidney Disease TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH